Unexplained developmental delay/learning disability: guidelines for best practice protocol for first line assessment and genetic/metabolic/radiological investigations
- 789 Downloads
Investigation of patients, particularly children, with unexplained global developmental delay (GDD)/learning disability (LD) has been challenging due to a lack of clear guidance from specialised centres. Limited knowledge of rare diseases and a poor understanding of the purpose or limitations of appropriate investigations have been some of the principal reasons for this difficulty.
A guideline development group was formed to recommend on appropriate, first line metabolic, genetic and radiological investigations for children and adults with unexplained GDD/ID.
Methods and recommendations
A comprehensive literature search was conducted, evaluated and reviewed by the guideline committee and a best practice protocol for first line assessment and genetic, metabolic and radiological investigations was decided upon after considering diagnostic yield, practicality, treatability and costs.
It is hoped that these recommendations will become national guidelines for the first line metabolic, genetic and radiological investigation of patients presenting with unexplained GDD/ID.
KeywordsGuidelines Global developmental delay Learning disability First line investigations
This guideline has been developed in collaboration with the following contributions:
Prof. A.J. Green, Dr. D.E. Barton, Dr. M. Sweeney: contributions from The Department of Clinical Genetics, Our Lady’s Children’s Hospital, Crumlin, Dublin 12, Ireland.
Dr. A.A. Monavari, Dr. E. Crushell, Dr. J. Hughes, Dr. I. Knerr: contributions from The National Centre for Inherited Metabolic Disorders, Temple Street Children’s University Hospital, Dublin 1, Ireland
Ms. P. Fitzsimons: contributions from The Department of Biochemistry, Temple Street Children’s University Hospital, Dublin 1, Ireland.
Dr. S. Macken: contributions from The Department of Developmental Paediatrics, Temple Street Children’s University Hospital, Dublin 1, Ireland.
- 1.Shevell M, Ashwal S, Donley D et al (2003) Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology 60(3):367–380PubMedCrossRefGoogle Scholar
- 2.Sherr EH, Shevell MI (2012) Global developmental delay and mental retardation/intellectual disability. Pediatric neurology: principles and practice, 5th edn. Elsevier Saunders, Philadelphia, pp 554–574Google Scholar
- 3.Central Statistics Office (2012) Census 2011 Profile 8-Our Bill of Health. The Stationary Office, Dublin, pp 22–23Google Scholar
- 14.National Metabolic Biochemistry Network, lead author Galloway P (2010) Best practice guidelines for the biochemical investigation of global developmental delay for inherited metabolic disorders (IMD), Version 2.0Google Scholar
- 26.UK Genetic guidelines network, UKGTN Testing Criteria. http://www.ukgtn.nhs.uk/gtn/digitalAssets/O/973_FragileXFullmutationinMales.pdfand_FragileXFullmutationinFemales.pdf. Accessed Nov 2014
- 30.Michelson DJ, Shevell MI, Sherr EH et al (2011) Evidence report: genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 77(17):1629–1635PubMedCrossRefGoogle Scholar
- 33.Honeycutt A, Dunlap L, Chen H, al Homsi G, Grosse S, Schendel D (2004) Economic costs associated with mental retardation, cerebral palsy, hearing loss and vision impairment United States, 2003. MMWR Morb Mortal Wkly Rep 53:57–59Google Scholar
- 35.The Online Metabolic and Molecular Bases of Inherited Disease (2014) http://ommbid.mhmedical.com/book.aspx?bookID=474 Academic Press: McGraw-Hill Medical